2,660
Participants
Start Date
October 19, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
May 31, 2026
FDA approved mRNA vaccines
This study is non-interventional as participants will have received an FDA approved mRNA COVID-19 vaccine prior to entering the study. The study protocol does not determine or allocate receipt of vaccine
Walgreens - 3298 S John Young Pkwy, Kissimmee
Walgreens - 811 Madison St, Oak Park
Walgreens - 7251 Lake St, River Forest
Walgreens - 1554 E 55th St, Chicago
Walgreens - 4385 S Archer Ave, Chicago
Walgreens - 17811 E US Highway 24, Independence
Walgreens - 3845 Broadway Blvd, Kansas City
Walgreens - 2630 NE Vivion, Kansas City
Walgreens - 7500 Metcalf Ave, Overland Park
Walgreens - 15100 W 87th Street Pkwy, Lenexa
Walgreens - 1919 W Gray St, Houston
Walgreens - 420 N Frazier St, Conroe
Walgreens - 7440 FM 1960 Rd E, Humble
Walgreens - 3316 Avenue H, Rosenberg
Walgreens - 8430 Broadway St, Pearland
Walgreens - 1445 W Craig Rd, North Las Vegas
Walgreens - 6401 W Charleston Blvd, Las Vegas
Walgreens - 215 Beach St, Malden
Walgreens - 3218 Atlantic Ave, Atlantic City
Walgreens - 520 Convery Blvd, Perth Amboy
Biomedical Advanced Research and Development Authority
FED